Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jose L. López Lorenzo"'
Autor:
David Martínez-Cuadrón, Juan E. Megías-Vericat, Cristina Gil, Teresa Bernal, Mar Tormo, Pilar Martínez-Sánchez, Carlos Rodríguez-Medina, Josefina Serrano, Pilar Herrera, José A. Pérez Simón, María J. Sayas, Juan Bergua, Esperanza Lavilla-Rubira, Maria Luz Amigo, Celina Benavente, Jose L. López Lorenzo, Manuel M. Pérez-Encinas, María B. Vidriales, Mercedes Colorado, Beatriz de Rueda, Raimundo García-Boyero, Sandra Marini, Julio García-Suárez, María López-Pavía, Maria I. Gómez-Roncero, Víctor Noriega, Aurelio López, Jorge Labrador, Ana Cabello, Claudia Sossa, Lorenzo Algarra, Mariana Stevenazzi, Antonio Solana-Altabella, Blanca Boluda, Pau Montesinos
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Treatment options for patients with secondary acute myeloid leukemia (sAML) and AML with myeloid-related changes (AMLMRC) aged 60 to 75 years are scarce and unsuitable. A pivotal trial showed that CPX-351 improved complete remission with/without inco
Externí odkaz:
https://doaj.org/article/f978279b26d241eca282876eec8ca76b
Autor:
Tamara Castaño-Bonilla, Juan M. Alonso-Dominguez, Eva Barragán, Rebeca Rodríguez-Veiga, Claudia Sargas, Cristina Gil, Carmen Chillón, María B. Vidriales, Raimundo García, Joaquín Martínez-López, Rosa Ayala, María J. Larrayoz, Eduardo Anguita, Rebeca Cuello, Alberto Cantalapiedra, Estrella Carrillo, Elena Soria-Saldise, Jorge Labrador, Isabel Recio, Lorenzo Algarra, Carlos Rodríguez-Medina, Cristina Bilbao-Syeiro, Juan A. López-López, Josefina Serrano, Erik De Cabo, María J. Sayas, María T. Olave, Joaquín Sánchez-García, Mamen Mateos, Carlos Blas, Jose L. López-Lorenzo, Daniel Lainez-Gonzalez, Juana Serrano, David Martínez-Cuadrón, Miguel A. Sanz, Pau Montesinos
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract FLT3-ITD mutations are detected in approximately 25% of newly diagnosed adult acute myeloid leukemia (AML) patients and confer an adverse prognosis. The FLT3-ITD allelic ratio has clear prognostic value. Nevertheless, there are numerous manu
Externí odkaz:
https://doaj.org/article/fdbb40702f114bf78acc458a1b88a71c
Autor:
David Martínez-Cuadrón, Juan E. Megías-Vericat, Cristina Gil, Teresa Bernal, Mar Tormo, Pilar Martínez-Sánchez, Carlos Rodríguez-Medina, Josefina Serrano, Pilar Herrera, José A. Pérez Simón, María J. Sayas, Juan Bergua, Esperanza Lavilla-Rubira, Maria Luz Amigo, Celina Benavente, Jose L. López Lorenzo, Manuel M. Pérez-Encinas, María B. Vidriales, Mercedes Colorado, Beatriz De Rueda, Raimundo García-Boyero, Sandra Marini, Julio García-Suárez, María López-Pavía, Maria I. Gómez-Roncero, Víctor Noriega, Aurelio López, Jorge Labrador, Ana Cabello, Claudia Sossa, Lorenzo Algarra, Mariana Stevenazzi, Antonio Solana-Altabella, Blanca Boluda, Pau Montesinos
Publikováno v:
Haematologica.
Treatment options for patients with secondary and myeloid related changes acute myeloid leukemia (sAML and AML-MRC) aged 60-75 years old are scarce and unsuitable. A pivotal trial showed that CPX-351 improved complete remission with/without incomplet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37a5407c2b18ec6246330ca8c70f3eff
https://doi.org/10.3324/haematol.2022.282506
https://doi.org/10.3324/haematol.2022.282506